Luca Hegedüs

796 total citations
35 papers, 601 citations indexed

About

Luca Hegedüs is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Luca Hegedüs has authored 35 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cell Biology. Recurrent topics in Luca Hegedüs's work include Cellular transport and secretion (6 papers), Melanoma and MAPK Pathways (6 papers) and Peptidase Inhibition and Analysis (6 papers). Luca Hegedüs is often cited by papers focused on Cellular transport and secretion (6 papers), Melanoma and MAPK Pathways (6 papers) and Peptidase Inhibition and Analysis (6 papers). Luca Hegedüs collaborates with scholars based in Hungary, Germany and Austria. Luca Hegedüs's co-authors include Ágnes Enyedi, Katalin Pászty, Rita Padányi, Béla Papp, Hyojin Cho, George L. Eliceiri, John T. Penniston, Balázs Hegedűs, Clemens Aigner and József Tı́már and has published in prestigious journals such as The Journal of Physiology, Biochemical and Biophysical Research Communications and Journal of Cell Science.

In The Last Decade

Luca Hegedüs

33 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Hegedüs Hungary 16 435 124 95 75 70 35 601
Zoltán Pethő Germany 12 275 0.6× 42 0.3× 55 0.6× 31 0.4× 24 0.3× 36 462
Lie Di United States 10 481 1.1× 79 0.6× 31 0.3× 98 1.3× 30 0.4× 12 706
Dimitri Lodygin Germany 8 560 1.3× 126 1.0× 47 0.5× 87 1.2× 48 0.7× 9 696
Gérald Bernatchez Canada 16 491 1.1× 133 1.1× 50 0.5× 119 1.6× 15 0.2× 20 781
Michael J. G. Milevskiy Australia 13 386 0.9× 98 0.8× 33 0.3× 167 2.2× 17 0.2× 26 541
Linda Henneman Netherlands 10 505 1.2× 325 2.6× 62 0.7× 128 1.7× 16 0.2× 16 914
Xiao Zhi China 14 588 1.4× 216 1.7× 46 0.5× 275 3.7× 18 0.3× 16 796
Wataru Nakajima Japan 13 400 0.9× 154 1.2× 81 0.9× 131 1.7× 15 0.2× 28 592
Romain Lara United Kingdom 7 522 1.2× 127 1.0× 286 3.0× 108 1.4× 184 2.6× 9 819
Christoph Datler United Kingdom 7 645 1.5× 93 0.8× 210 2.2× 113 1.5× 19 0.3× 9 805

Countries citing papers authored by Luca Hegedüs

Since Specialization
Citations

This map shows the geographic impact of Luca Hegedüs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Hegedüs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Hegedüs more than expected).

Fields of papers citing papers by Luca Hegedüs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Hegedüs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Hegedüs. The network helps show where Luca Hegedüs may publish in the future.

Co-authorship network of co-authors of Luca Hegedüs

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Hegedüs. A scholar is included among the top collaborators of Luca Hegedüs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Hegedüs. Luca Hegedüs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collaud, Stéphane, Uta Dirksen, Dirk Theegarten, et al.. (2025). Characterization of a novel sarcoma cell line with an EWSR1::POU2AF3 fusion. Pathology & Oncology Research. 31. 1611986–1611986.
2.
3.
Molnár, Eszter, Luca Hegedüs, Ivan Ranđelović, et al.. (2024). Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors. British Journal of Cancer. 130(6). 1059–1072. 15 indexed citations
4.
Molnár, Eszter, et al.. (2024). Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer. Pathology & Oncology Research. 30. 1611948–1611948. 4 indexed citations
5.
Naffa, Randa, Luca Hegedüs, Tamás Hegedűs, et al.. (2023). Plasma membrane Ca2+ pump isoform 4 function in cell migration and cancer metastasis. The Journal of Physiology. 602(8). 1551–1564. 5 indexed citations
6.
Hegedüs, Luca, Fabian Mairinger, Till Ploenes, et al.. (2023). TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy. Lung Cancer. 178. 237–246. 7 indexed citations
7.
Hegedüs, Luca, Elisabeth Livingstone, Ágnes Bánkfalvi, et al.. (2022). The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition. International Journal of Molecular Sciences. 23(6). 3324–3324. 7 indexed citations
8.
Hegedüs, Luca, Elisabeth Livingstone, Ildikó Kovács, et al.. (2021). Allosteric and ATP-Competitive MEK-Inhibition in a Novel Spitzoid Melanoma Model with a RAF- and Phosphorylation-Independent Mutation. Cancers. 13(4). 829–829. 4 indexed citations
9.
Stockhammer, Paul, Luca Hegedüs, Till Ploenes, et al.. (2021). HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line. Pathology & Oncology Research. 27. 636088–636088. 7 indexed citations
10.
Molnár, Eszter, Tamás Garay, Luca Hegedüs, et al.. (2020). Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations. International Journal of Molecular Sciences. 21(20). 7649–7649. 6 indexed citations
11.
Stockhammer, Paul, Luca Hegedüs, Gábor Lotz, et al.. (2020). HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model. Lung Cancer. 144. 20–29. 15 indexed citations
12.
Molnár, Eszter, Senji Shirasawa, I. Jalsovszky, et al.. (2020). Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In Vivo. Pathology & Oncology Research. 26(3). 1957–1969. 12 indexed citations
13.
Pászty, Katalin, Luca Hegedüs, Gergely Szakács, et al.. (2018). Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells. BMC Cancer. 18(1). 1029–1029. 36 indexed citations
14.
Hegedüs, Luca, Rita Padányi, Mária Judit Molnár, et al.. (2017). Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK. Frontiers in Oncology. 7. 95–95. 23 indexed citations
15.
Pászty, Katalin, Rita Padányi, Luca Hegedüs, et al.. (2014). Histone deacetylase inhibitor- and PMA-induced upregulation of PMCA4b enhances Ca2+ clearance from MCF-7 breast cancer cells. Cell Calcium. 55(2). 78–92. 28 indexed citations
16.
Pászty, Katalin, et al.. (2013). A C-terminal di-leucine motif controls plasma membrane expression of PMCA4b. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(12). 2561–2572. 14 indexed citations
17.
Penniston, John T., et al.. (2013). Apart from its basic function the plasma membrane Ca2+ATPase regulates Ca2+ signaling by controlling phosphatidylinositol-4,5-bisphosphate levels. Journal of Cell Science. 127(Pt 1). 72–84. 27 indexed citations
18.
Mauer, Amy S., Katalin Pászty, Luca Hegedüs, et al.. (2012). Plasma membrane calcium pump (PMCA) isoform 4 is targeted to the apical membrane by the w-splice insert from PMCA2. Cell Calcium. 51(2). 171–178. 6 indexed citations
19.
Hegedüs, Luca, et al.. (2008). Additional MDA‐MB‐231 breast cancer cell matrix metalloproteinases promote invasiveness. Journal of Cellular Physiology. 216(2). 480–485. 73 indexed citations
20.
Pászty, Katalin, Luca Hegedüs, Rita Padányi, et al.. (2007). Cleavage of the Plasma Membrane Ca+ATPase during Apoptosis. Annals of the New York Academy of Sciences. 1099(1). 440–450. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zoltán Pethő Breakdown of academic impact, for papers by Lie Di Breakdown of academic impact, for papers by Dimitri Lodygin Breakdown of academic impact, for papers by Gérald Bernatchez Breakdown of academic impact, for papers by Michael J. G. Milevskiy Breakdown of academic impact, for papers by Linda Henneman Breakdown of academic impact, for papers by Xiao Zhi Breakdown of academic impact, for papers by Wataru Nakajima Breakdown of academic impact, for papers by Romain Lara Breakdown of academic impact, for papers by Christoph Datler
Rankless by CCL
2026